<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2025-11-17 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers." This guidance finalizes the revised draft guidance issued on November 2, 2022, and replaces the final guidance of the same title issued in June 2016 and updated in October 2017. The guidance addresses frequently asked questions, including those related to the implementation of FDA's regulatio...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2025-19984</p>
    <p><strong>Publication Date:</strong> 2025-11-17</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2025/11/17/2025-19984/expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers-guidance-for">https://www.federalregister.gov/documents/2025/11/17/2025-19984/expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2025-19984</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
